Qvar Related Published Studies
Well-designed clinical trials related to Qvar (Beclomethasone Inhalation)
Beclomethasone inhaler versus intravenous lidocaine in the prevention of postoperative airway and throat complaints: a randomized, controlled trial. [2008.01]
Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients. [2008]
Efficacy and safety of once or twice daily inhalation of extrafine HFA beclomethasone dipropionate in patients with mild to moderate asthma. [2007.11]
Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis. [2007.10]
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size. [2007.09]
Meta-analysis: the efficacy of rectal beclomethasone dipropionate vs. 5-aminosalicylic acid in mild to moderate distal ulcerative colitis. [2007.07.01]
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. [2007.05.15]
Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma. [2007.05]
Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate. [2007.03]
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease. [2007.01.23]
Usefulness of QVAR for the treatment of bronchial asthma--with and without use of an inhalation device. [2006.10]
Adrenal axis suppression unrelated to the dynamics of dosing with beclomethasone monopropionate. [2006.09.19]
Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: a 56-week randomized double-blind study. [2006.06]
Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study. [2006.06]
Beclomethasone dipropionate attenuates airways hyperresponsiveness to neurokinin A and histamine in asthma. [2006.06]
A comparison of 2 extrafine hydrofluoroalkane-134a-beclomethasone formulations on methacholine hyperresponsiveness. [2006.03]
Effect of beclomethasone dipropionate and dexamethasone isonicotinate on lung function, bronchoalveolar lavage fluid cytology, and transcription factor expression in airways of horses with recurrent airway obstruction. [2006.03]
Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. [2006.01]
Comparison of fenspiride with beclomethasone as adjunctive anti-inflammatory treatment in patients with chronic obstructive pulmonary disease. [2006]
Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. [2005.11]
Effect of beclomethasone dipropionate (BDP) as extrafine aerosol on bronchoalveolar lavage (BAL) lymphocytes in chronic sarcoidosis. [2005.10]
Comparison of the efficacy and safety of budesonide turbuhaler administered once daily with twice the dose of beclomethasone dipropionate using pressurised metered dose inhaler in patients with mild to moderate asthma. [2005.07]
Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. [2005.07]
Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma. [2005.07]
Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide. [2005.06]
Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma. [2005.05]
Study on serum and urinary cortisol levels of asthmatic patients after treatment with high dose inhaled beclomethasone dipropionate or budesonide. [2005.04]
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial. [2005.04]
Treatment of exercise-induced asthma with beclomethasone dipropionate in children with asthma. [2004.12]
[Lung functioning changes of asthmatic adults in treatment with cromolyn sodium and beclomethasone] [2004.09]
A single blinded randomised trial to compare the efficacy and safety of once daily budesonide (400microg) administered by turbuhaler with beclomethasone dipropionate (400microg) given twice daily through a metered-dose inhaler in patients with mild to moderate asthma. [2004.06]
Safety and efficacy of HFA-134a beclomethasone dipropionate extra-fine aerosol over six months. [2004.03]
Randomized trial of inhaled beclomethasone dipropionate versus theophylline for moderate asthma during pregnancy. [2004.03]
Hydrofluoroalkane-134a beclomethasone as a dominant economic asthma therapy. [2003.12]
[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination] [2003.11]
Effect of single inhalation of a salbutamol, ipratropium bromide and beclomethasone on mucociliary clearance in patients with chronic obstructive airway disease. [2003.10]
Beclomethasone-induced vasoconstriction in women with major depressive disorder. [2003.09]
Improvement in health-related quality of life with fluticasone propionate compared with budesonide or beclomethasone dipropionate in adults with severe asthma. [2003.09]
Efficacy, safety, and acceptance of beclomethasone dipropionate administered via a new dry powder Inhaler or a standard CFC metered-dose inhaler in asthma patients. [2003.07]
A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis. [2003.05]
Randomized controlled trial of three different doses of aerosol beclomethasone versus systemic dexamethasone to promote extubation in ventilated premature infants. [2003.05]
Effect of inhalation of salbutamol, beclomethasone dipropionate & ipratropium bromide on mucociliary clearance in some patients with chronic stable bronchial asthma. [2003.04]
Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis. [2003.03]
Salbutamol, beclomethasone or sodium chromoglycate suppress coughing induced by iv fentanyl. [2003.03]
Influence of particle size on lung deposition and pharmacokinetics of beclomethasone dipropionate in children. [2003.03]
Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. [2003.03]
Salbutamol and/or beclomethasone diproprionate in asthma. [2003.02]
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone. [2003.01]
Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study. [2002.12]
Effects of montelukast and beclomethasone on airway function and asthma control. [2002.12]
The clinical efficacy of fluticasone propionate (Fluvent) compared with beclomethasone dipropionates (Becotide) in patients with mild to moderate brochial asthma at the University College Hospital, Ibadan, Nigeria. [2002.10]
Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. [2002.10]
Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma. [2002.07]
Comparison of mometasone furoate administered by metered dose inhaler with beclomethasone dipropionate. [2002.07]
Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial. [2002.07]
Beclomethasone dipropionate and salbutamol by metered dose inhaler in infants and small children with recurrent wheezing. [2002.07]
Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma. [2002.06]
Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate. [2002.06]
Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. [2002.06]
Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. [2002.06]
Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant. [2002.01]
Initial improvements in lung function and bronchial hyperresponsiveness are maintained during 5 years of treatment with inhaled beclomethasone dipropionate and terbutaline. [2002.01]
The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study. [2002]
Inhaled beclomethasone dipropionate improves acoustic measures of voice in patients with asthma. [2001.12]
Oral beclomethasone dipropionate in patients with mild to moderate ulcerative colitis: a dose-finding study. [2001.11]
Effect of salmeterol and salmeterol plus beclomethasone on saliva flow and IgA in patients with moderate-persistent chronic asthma. [2001.11]
Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone. [2001.09.15]
Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma. [2001.08]
Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. [2001.07]
Comparison of beclomethasone dipropionate delivery by easyhaler dry powder inhaler and pMDI plus large volume spacer. [2001.06]
A comparison of clinical use of fluticasone propionate and beclomethasone dipropionate in pediatric asthma. [2001.06]
Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older. [2001.06]
A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate. [2001.05]
Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. [2001.05]
Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients. [2001.03]
Intranasal beclomethasone dipropionate in the treatment of common cold. [2001.03]
Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. [2001.03]
Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma. [2001.03]
Efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI in Japanese patients with moderately persistent asthma. [2001.03]
Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. [2001.02]
Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. [2001.01]
Serum potassium levels, CPK-MB and ECG in children suffering asthma treated with beclomethasone or beclomethasone-salmeterol. [2001.01]
Therapeutic equivalence study of two formulations (innovator v. generic) of beclomethasone dipropionate in adult asthmatic patients. [2001.01]
Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. [2001]
Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. [2001]
Assessment of the systemic effects of beclomethasone dipropionate inhaled via Easyhaler or via Diskhaler in healthy male volunteers. [2000.12]
Meter-dosed, inhaled beclomethasone initiated at birth to prevent bronchopulmonary dysplasia. [2000.10]
Effects of early inhaled beclomethasone therapy on tracheal aspirate inflammatory mediators IL-8 and IL-1ra in ventilated preterm infants at risk for bronchopulmonary dysplasia. [2000.10]
Pulmonary function and adrenal gland suppression with incremental doses of aerosolized beclomethasone dipropionate in horses with recurrent airway obstruction. [2000.08.01]
Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group. [2000.08]
Beclomethasone dipropionate Easyhaler is as effective as budesonide Turbohaler in the control of asthma and is preferred by patients. German Study Group. [2000.07]
Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG). [2000.06]
Post-inhalation bronchoconstriction by beclomethasone dipropionate: a comparison of two different CFC propellant formulations in asthmatics. [2000.06]
Changes in nasal leukocytes and epithelial cells associated with topical beclomethasone treatment. [2000.06]
Effect of one year treatment with inhaled fluticasone propionate or beclomethasone dipropionate on bone density and bone metabolism: a randomised parallel group study in adult asthmatic subjects. [2000.05]
Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler) for the treatment of adult asthma. Amsterdam Clinical Study Group. [2000.04]
Treating asthma in children with beclomethasone dipropionate: Pulvinal versus Diskhaler. [2000.03]
Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. [2000.02]
|
